COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021

Insob Hwang, Kyeongeun Park, Tae Eun Kim, Yunhyung Kwon, Yeon-Kyeng Lee

Osong Public Health and Research Perspectives · 2021 · 19 citations · 4 references

DOIFull text

Open access

Abstract

The commonly reported symptoms were similar to those described in clinical trials. Most reported adverse events were non-serious, and the reporting rate of adverse events following COVID-19 vaccination was higher in women than in men (581 vs. 315 per 100,000 vaccinations). Confirmed anaphylaxis was reported in 5.8 cases per 1,000,000 vaccinations.

References

4